Position in VTVT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,222,495
-$81,762 QoQ
Shares Held
32,470
-1.3% QoQ
Ownership
0.821%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 45 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTVT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. VTVT ranks #308 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in VTVT
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,222,495 | 32,470 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,304,257 | 32,886 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,127,478 | 28,194 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $357,208 | 15,298 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $192,990 | 12,866 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $218,872 | 12,637 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $160,652 | 11,634 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $139,814 | 10,307 | Shares | Defined | 2024-11-12 | |
| 2023-09-30 | $112,870 | 236,131 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $214,116 | 289,347 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $233,792 | 289,347 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $191,837 | 289,347 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $281,300 | 290,000 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $274,963 | 366,618 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $250,943 | 347,567 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $345,891 | 347,630 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $531,881 | 347,635 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $447,336 | 196,200 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $754,321 | 267,490 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $316,633 | 170,233 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $299,595 | 169,263 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $379,689 | 168,751 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $201,388 | 105,439 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||